enabling human biology in vitro
denovoMATRIX offers modular biomimetic matrices that can be tailored to recreate a large variety of extracellular matrices for any cell type.
easy to use
modular
Tailored environment for each cell type.
biologically relevant
chemically defined
No batch-to-batch variation.
GxP-certifiable
we are denovoMATRIX
our product lines
screenMATRIX.
Discover the ideal microenvironment for your application.
The screenMATRIX is the fastest way to test a large variety of factors for isolating, maintaining or differentiating your cells. screenMATRIX consists of a cell culture plate containing a different microenvironment in each well.
myMATRIX.
The best substrate for your cell culture.
The myMATRIX is a unique biomimetic coating, tailored to your specific application. The myMATRIX is a distinct combination of sulfated polysaccharides and biomimetic peptides, to get you the results you need.
Consulting services.
Let us do the heavy lifting.
We develop, characterize and manufacture extracellular matrix-mimetic coatings for all of your cell culture needs.
discover YOUR cell culture solution
with screenMATRIX
applications
stem cell research
stem cell research
We provide coatings tailored for pluripotency maintenance, proliferation, patterning or differentiation.
tissue models
tissue models
A variety of tissue models can be recreated on our coatings, providing advantages in model maintainance time, clarity of results and repeatable outcomes.
cell based therapy
cell based therapy
FDA approved compounds in our coatings enable their use as cell expansion platforms.
we mimic the cell microenvironment that determines cell fate and function
publications
Thin layer biomatrix coatings for screening of Extracellular matrix features
Characterization of a cell compatible non-covalent peptide heparin hydrogel
A repertoire of conjugable tags for controlling the release of drugs from noncovalent peptide-oligosaccharide hydrogels
Preparation of homogeneous, tunable, and robust hydrogel beads from peptide–polyethylene glycol conjugates and oligosaccharides under mild, cell-compatible conditions using a noncovalent crosslinking mechanism.
Injectable Non-covalent Peptide-oligosaccharide hydrogel for in vivo applications
biomatrices created de novo for each cell type
references
investors
press
increase biological relevance and reproducibility
awards
support
denovoMATRIX GmbH is supported and receives funding by the European Regional Development Fund (ERDF) and the Free State of Saxony to further develop its denovoMATRIX platform technology for new application areas.
